The science of health 
Home 
Questo sito in ItalianoSunday 05 September 2010
In its first sixty years of existence, Alfa Wassermann has become a pharmaceutical group that holds an internationally prominent position and constantly invests in research and technological innovation. With growth has come continuous modernization.
Step by step the company has enterred new markets all over the world. Nevertheless, it has remained closely attached to its place of birth.
Alfa Wassermann’s philosophy remains the same: to apply advances in medical science and new findings in biology and genomics for the benefit of all people.
Alfa Wassermann considers taking care of people’s health as its fundamental objective. In order to do so, it has always pursued a policy based on high moral principles.
Alfa Wassermann is engaged in the research, manufacturing and worldwide distribution of pharmaceutical products and biomedical instruments for human healthcare.
A SUCCESSFUL CORPORATE STRATEGY
RESEARCH
Investing in research and development of new molecules has always been one of Alfa Wassermann’s priorities and guidelines.
Innovation is crucial in the pharmaceutical industry, where success often depends on a strong commitment to focusing on specific therapeutic areas of competence.
TECHNOLOGY
Alfa Wassermann knows well that results can be achieved only by investing in advanced technology, that provides a high level of efficiency and safety in product manufacturing. When dealing with human health, there is no room for error. Technology ensures in every phase of production the high quality standards required by ourselves and by the Regulatory Agencies.
INTERNATIONALIZATION
Internationalization is the third keystone in Alfa Wassermann’s growth strategy. The company has been expanding beyond its national borders into new markets and challenges.
